Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism

The protective effect of cruciferae-derived sulforaphane (SFN) on diabetic cardiomyopathy (DCM) has garnered increasing attention. However, no studies have specifically explored its mechanistic involvement in cardiac substrate metabolism and mitochondrial function. To address this gap, Type 2 diabet...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pan Wang, Ziling Wang, Xinyuan Jin, Mengdi Zhang, Mengfan Shen, Dan Li
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-05-01
Schriftenreihe:	Antioxidants
Schlagworte:	sulforaphane cruciferae diabetic cardiomyopathy diabetes mellitus lipotoxicity substrate metabolism
Online-Zugang:	https://www.mdpi.com/2076-3921/14/5/603
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!